β¨ Medicines Classification
NEW ZEALAND GAZETTE
No. 9
contraception, for the treatment of nausea associated with emergency contraception.
Salicylic acid; in medicines containing more than 40%
Silver sulfadiazine; except for external use in packs containing 50 grams or less
Schedule 3
Pharmacy-only Medicines
Aciclovir; for external use for the treatment of herpes labialis except in medicines containing 5% or less and in tubes containing 3 grams or less
Amethocaine; for external use in medicines containing 10% or less and more than 2%
Atropa belladonna; for external use in medicines containing 0.03% of the alkaloids of belladonna; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of the alkaloids of belladonna
Atropine; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose; in medicines containing atropine sulfate for the treatment of organophosphorus poisoning either in packs of up to 20 tablets containing 0.6 milligrams or less per tablet or in injections in packs of 5 or less containing 0.6 milligrams per millilitre or less; except when used as an antidote in a device designed for self-injection; except when sold by licensees under the Toxic Substances Regulations
Benzocaine; for external use in medicines containing 10% or less and more than 2%
Benzydamine; for external use
Bifonazole; for external use except in medicines for tinea pedis only or in shampoos containing 1% or less
Cinchocaine; for external use in medicines containing 0.5% or less
Datura spp; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Duboisia leichhardtii; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Duboisia myoporides; for oral use in liquid form in medicines containing 0.03% or less and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose form and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Folic acid; in medicines containing more than 500 micrograms per recommended daily dose
Folinic acid; in medicines containing more than 500 micrograms per recommended daily dose
Hyoscine; for transdermal use in medicines containing 2 milligrams or less of total solanaceous alkaloids per dose unit; for oral use in liquid form in medicines containing 0.03% and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose unit and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Hyoscyamine; for external use in medicines containing 0.03% or less of total solanaceous alkaloids; for oral use in liquid form in medicines containing 0.03% and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose or in solid dose form in medicines containing 0.3 milligrams or less per dose unit and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Hyoscyamus niger; for oral use in liquid form in medicines containing 0.03% and 0.3 milligrams or less per dose and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids or in solid dose form in medicines containing 0.3 milligrams or less per dose unit and not more than 1.2 milligrams per recommended daily dose of total solanaceous alkaloids
Ibuprofen; for external use; for oral use in either liquid form in packs containing not more than 4 grams or in solid dose form containing not more than 200 milligrams per dose form and when in medicines which have received the consent of the Minister or the Director-General to their sale as pharmacy-only medicines and which are sold in the manufacturer's original pack
Lignocaine; for external use in medicines containing 10% or less and more than 2%; for urethral use
Minoxidil; for external use in medicines containing 5% or less
Nystatin; for dermal use
Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin
Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 10% or less of podophyllin
Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 0.5% or less
Potassium chlorate; except in medicines containing 10% or less
Prilocaine; for dermal use in medicines containing 10% or less
Pyrithione zinc; for external use in medicines containing more than 2%
Sabadilla; in packs containing 18 milligrams or less of total alkaloids except in packs containing 1.8 milligrams or less and a recommended daily dose of not more than 0.6 milligrams of total alkaloids
Silver; except in oral solutions containing 0.3% or less or other medicines containing 1% or less
Silver sulfadiazine; for external use in packs containing 50 grams or less
Medicines for General Sale
Please note that the following medicines are no longer classified as prescription medicines, restricted medicines or pharmacy-only medicines. As such, they are now available for general sale.
Aciclovir; for external use for the treatment of herpes labialis in medicines containing 5% or less and tubes containing 3 grams or less
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2003, No 9
Gazette.govt.nz —
NZ Gazette 2003, No 9
β¨ LLM interpretation of page content
π₯
Classification of Medicines
(continued from previous page)
π₯ Health & Social Welfare25 January 2003
Medicines Act, Classification, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines